DNA induction of MDM2 promotes proliferation of human renal mesangial cells and alters peripheral B cells subsets in pediatric systemic lupus erythematosus
DNA induction of MDM2 promotes proliferation of human renal mesangial cells and alters peripheral B cells subsets in pediatric systemic lupus erythematosus
复制标题
MDM2 的 DNA 诱导促进人肾系膜细胞增殖并改变儿童系统性红斑狼疮的外周 B 细胞亚群
DOI:
10.1016/j.molimm.2018.01.003
复制
发表时间:
2018-02
影响因子:
3.6
通讯作者:
Tongxin Chen
中科院分区:
文献类型:
--
作者:
Chenxing Zhang;Ji Chen;Li Cai;Jing Wu;Jiayuan Wang;Lanfang Cao;Wei Zhou;Tongxin Chen
The study is aimed to investigate the role of MDM2 in the pathogenesis of lupus nephritis (LN) in pediatric SLE (pSLE). We confirmed that MDM2 expression was increased in peripheral blood mononuclear cells (PBMCs) as well as renal specimen of SLE compared with that of controls by western blot and immunofluorescence staining. Percentage of apoptotic and necrotic CD4+T, CD8+T and B cells were detected by flow cytometry respectively and levels of plasma cell free DNA (cfDNA) were quantified in SLE and healthy controls (HC). We also proved that elevated apoptotic and necrotic CD4+T cells were the main cause for increased plasma levels of cfDNA in pSLE. Additionally, upon DNA transfection MDM2 increased while P53 and P21 decreased in human renal mesangial cells (HRMC), with concomitant increase in proliferation rate and proportion of cells in S phase, as demonstrated by cell proliferation assay and cell cycle analysis. However, MDM2 inhibition reversed the trend. Furthermore, percentage of switched memory B cells decreased and proportion of double negative B cells increased upon blockage of MDM2 in PBMC. In summary, our study provided the first evidence that DNA induction of MDM2 promotes proliferation of HRMC and alters peripheral B cells subsets in pSLE. Thus our study has not only elucidated the pathogenesis of MDM2 in pediatric LN but also provided a novel target for drug development. In conclusion, our data suggested that apoptosis, cfDNA and MDM2 could form a pathological axis in SLE, especially in pSLE.
登录
查看更多内容
影响因子:
7.3
作者:
Darrah E;Andrade F
通讯作者:
Andrade F
影响因子:
3
作者:
Kumar D;Bhaskaran M;Alagappan L;Tori D;Yadav I;Konkimalla S;Magoon S;Singhal PC
通讯作者:
Singhal PC
影响因子:
3.4
作者:
Atef Elmougy;A. Sarhan;A. Hammad;A. El-refaey;M. Zedan;R. Eid;Wafaa Limon;A. A. Elrahman-A.;Fatma Elhussieni;Enas El-Sherbeny;A. Bakr
通讯作者:
Atef Elmougy;A. Sarhan;A. Hammad;A. El-refaey;M. Zedan;R. Eid;Wafaa Limon;A. A. Elrahman-A.;Fatma Elhussieni;Enas El-Sherbeny;A. Bakr
影响因子:
5.1
作者:
Hao Zhao;Ruijuan Shen;Xiao-bin Dong;Yi Shen
通讯作者:
Hao Zhao;Ruijuan Shen;Xiao-bin Dong;Yi Shen
影响因子:
3.7
作者:
gren, J.;Thiemermann, C.;Aasen, A. O.
通讯作者:
Aasen, A. O.